Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.7700
+0.0350
+(4.76%)
As of 8:10:17 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-144,162
-144,162
-202,464
-146,930
-84,911
Investing Cash Flow
149,845
149,845
-1,148,383
-274,492
132,297
Financing Cash Flow
-81,496
-81,496
-1,419
-31,098
-21,670
End Cash Position
330,117
330,117
403,768
1,727,411
2,210,504
Capital Expenditure
-19,158
-19,158
-14,401
-7,198
-38,960
Issuance of Capital Stock
--
--
961
--
--
Repurchase of Capital Stock
-78,961
-78,961
--
-28,689
-19,601
Free Cash Flow
-163,320
-163,320
-216,865
-154,128
-123,871
12/31/2020 - 8/14/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KK3A.DU Cytokinetics Inc
44.80
+1.82%
1VT.BE Viking Therapeutics Inc
27.46
+0.70%
EWTX Edgewise Therapeutics, Inc.
25.75
+2.65%
ATNM Actinium Pharmaceuticals, Inc.
1.1500
0.00%
BMEA Biomea Fusion, Inc.
2.9408
+3.55%
AKRO Akero Therapeutics, Inc.
48.65
+2.49%
CYTK Cytokinetics, Incorporated
47.54
+1.91%
ALT Altimmune, Inc.
6.01
+1.69%